Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Inventory: 2018-2024

Historic Inventory for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to $55.7 million.

  • Pharming Group N.V's Inventory rose 7.89% to $67.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.1 million, marking a year-over-year increase of 7.89%. This contributed to the annual value of $55.7 million for FY2024, which is 1.89% down from last year.
  • Pharming Group N.V's Inventory amounted to $55.7 million in FY2024, which was down 1.89% from $56.8 million recorded in FY2023.
  • Pharming Group N.V's Inventory's 5-year high stood at $56.8 million during FY2023, with a 5-year trough of -$2.4 million in FY2021.
  • Over the past 3 years, Pharming Group N.V's median Inventory value was $55.7 million (recorded in 2024), while the average stood at $36.9 million.
  • In the last 5 years, Pharming Group N.V's Inventory plummeted by 278.95% in 2021 and then skyrocketed by 2,981.79% in 2023.
  • Pharming Group N.V's Inventory (Yearly) stood at -$646,000 in 2020, then plummeted by 278.95% to -$2.4 million in 2021, then increased by 19.49% to -$2.0 million in 2022, then soared by 2,981.79% to $56.8 million in 2023, then fell by 1.89% to $55.7 million in 2024.